Effect of Rifampin on the Pharmacokinetics of Ixabepilone in Patients With Advanced Cancer.

Trial Profile

Effect of Rifampin on the Pharmacokinetics of Ixabepilone in Patients With Advanced Cancer.

Completed
Phase of Trial: Phase I

Latest Information Update: 14 Mar 2016

At a glance

  • Drugs Ixabepilone; Rifampicin
  • Indications Solid tumours
  • Focus Pharmacokinetics
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 26 May 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 13 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top